Investing Profile

Anne Portwich

VCInvestor
Partner at EQT Group
eqtgroup.com/about/people/ann...Amsterdam, Netherlands
Photo of Anne Portwich, Partner at EQT Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Moving Capital Network
963 CONNECTIONS
EQT Group Network
35 CONNECTIONS
LSP Network
11 CONNECTIONS
LSP Network
11 CONNECTIONS
LSP Network
11 CONNECTIONS
cb
EQT Group Partner
$11.0M - $65.0M
$25.0M
5
CompanyStageDateRound SizeTotal Raised
Perfuze
Series UnknownMar 2025$24M
Series AFeb 2022$26M
$53M
Co-investors: Daniel O'Mahony (Seroba Life Sciences), John Yianni (Earlybird Venture Capital)
NUA Surgical
Series ADec 2024$7M
$7M
iSTAR Medical
Series CSep 2019$44M
$44M
Neuravi
Series BJun 2015$22M
$22M
Co-investors: René Kuijten (EQT Group)
Scientist and Project Leader OctoplusPresent
Analyst LSPPresent
Associate LSPPresent
Investment Manager LSPPresent
Board Member ActoGeniX N.V.Present
Board Member NexstimPresent
Board Member MendorPresent
Board Member Moving CapitalPresent
Board Member MedEyePresent
Board Member NeuraviPresent
Board Member Vivasure Medical Ltd.Present
Board Member KaleidoPresent
Board Member iSTAR MedicalPresent
Board Member INNOVOPresent
Board Observer LUMA VisionPresent
Board Member PerfuzePresent
Member of the Investment Committee EQT FoundationPresent
Board Member NUA Surgical®Present
Partner LSPPresent
Partner EQT GroupPresent
Leibniz Universität Hannover Master of Science - MS Biochemistry
Max Planck Society Doctor of Philosophy - PhD Biochemistry / Microbiology
Sign in with Google →
Sign in with Google →